相关实验视频
Updated: Jul 4, 2025

04:49
Technique for Intranasal Administration of α-Synuclein Aggregates
Published on: November 8, 2024
466
在列维体疾病中,LRP10和α-synuclein传播
Ana Carreras Mascaro1, Martyna M Grochowska1, Valerie Boumeester1
1Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands.
Cellular and molecular life sciences : CMLS
|February 5, 2024
概括
自体主导的LRP10变体与莱维体病 (LBD) 有关. 这项研究揭示了LRP10影响α-synuclein分泌,并可能在LBD病变发生过程中发挥作用.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
背景情况:
- 在LRP10的自体主导变异与勒维体疾病 (LBDs) 相关,包括帕金森病 (PD),帕金森病痴呆症 (PDD) 和勒维体痴呆症 (DLB).
- 在LBD病变发生过程中LRP10的确切作用在机理上尚不清楚,尽管LRP10在受影响个体的莱维体中被发现.
研究的目的:
- 研究LBDs中的LRP10细胞机制.
- 探索LRP10和α-synuclein在疾病发病过程中的相互作用.
主要方法:
- 研究了野生型LRP10的分泌和内部化通过细胞外囊泡 (EVs) 和克拉特林依赖性内细胞化.
- 在iPSC衍生的脑器官中,在自抑制下检查LRP10分泌.
- 分析了LRP10过度表达对α-synuclein分泌和水平的影响.
- 在患者衍生天体细胞中的LRP10变异的特征及其对LRP10和α-synuclein的影响.
主要成果:
- 野生类型的LRP10通过EVs分泌,并通过克拉特林依赖性内细胞结合体内化,分泌对自抑制敏感.
- 过度表达LRP10会增加α-synuclein分泌并改变细胞内α-synuclein水平.
- 一种患者衍生的LRP10拼接变体 (LRP10^splice) 结合野生型LRP10,降低其水平,并对抗其对α-synuclein的影响.
结论:
- 通过调节细胞内和细胞外α-synuclein水平,LRP10在LBD中发挥功能作用.
- LRP10拼接变体通过破坏正常的LRP10功能和影响α-synuclein来促进LBD病变.
- 这些发现突出了LRP10和α-synuclein通路的重点,突出了LBD的潜在治疗目标.
相关概念视频
Neural Regulation
39.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.4K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Parkinson's Disease: Overview
547
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
547

